Crawford Nomination Clears OIG Hurdle To Face Committee Vote, Plan B Hold
This article was originally published in The Tan Sheet
Executive Summary
The conclusion of the HHS Inspector General's investigation into allegations against FDA Commissioner nominee Lester Crawford likely will bring the agency's delay of the Plan B emergency contraceptive switch application back into the foreground